Skip to main content
. 2024 Mar 22;15:1342530. doi: 10.3389/fendo.2024.1342530

Figure 5.

Figure 5

Forest plots for BCVA at 3 months and 6 months. TA, intravitreal triamcinolone; IVB, intravitreal bevacizumab; LP, laser, macroscopic laser, grid laser and focal/grid laser; TA+LP, intrareal triamcinolone combined with laser; DEX, intravitreal dexamethasone; IVB+TA, intravitreal bevacizumab combined with triamcinolone; DEX+LP, intrareal dexamethasone combined with laser; IVR, intravitreal ranibizumab.